Recurring nodular scleritis following inactivated vaccination for COVID‐19

KEY CLINICAL MESSAGE: Though COVID‐19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. ABSTRACT: Since the COVID‐19 global outbreak, man...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyman, Alireza, Pourazizi, Mohsen, Dehghani, Shakiba, Ghorbani, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264956/
https://www.ncbi.nlm.nih.gov/pubmed/37323271
http://dx.doi.org/10.1002/ccr3.7420
_version_ 1785058435423797248
author Peyman, Alireza
Pourazizi, Mohsen
Dehghani, Shakiba
Ghorbani, Sarah
author_facet Peyman, Alireza
Pourazizi, Mohsen
Dehghani, Shakiba
Ghorbani, Sarah
author_sort Peyman, Alireza
collection PubMed
description KEY CLINICAL MESSAGE: Though COVID‐19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. ABSTRACT: Since the COVID‐19 global outbreak, many types of vaccines have been introduced. These vaccines have been associated with some adverse effects including ocular manifestations. Herein, we report a case of a patient who developed nodular scleritis shortly after receiving the first and second doses of the inactivated COVID‐19 vaccine, Sinopharm.
format Online
Article
Text
id pubmed-10264956
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102649562023-06-15 Recurring nodular scleritis following inactivated vaccination for COVID‐19 Peyman, Alireza Pourazizi, Mohsen Dehghani, Shakiba Ghorbani, Sarah Clin Case Rep Case Report KEY CLINICAL MESSAGE: Though COVID‐19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. ABSTRACT: Since the COVID‐19 global outbreak, many types of vaccines have been introduced. These vaccines have been associated with some adverse effects including ocular manifestations. Herein, we report a case of a patient who developed nodular scleritis shortly after receiving the first and second doses of the inactivated COVID‐19 vaccine, Sinopharm. John Wiley and Sons Inc. 2023-06-13 /pmc/articles/PMC10264956/ /pubmed/37323271 http://dx.doi.org/10.1002/ccr3.7420 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Peyman, Alireza
Pourazizi, Mohsen
Dehghani, Shakiba
Ghorbani, Sarah
Recurring nodular scleritis following inactivated vaccination for COVID‐19
title Recurring nodular scleritis following inactivated vaccination for COVID‐19
title_full Recurring nodular scleritis following inactivated vaccination for COVID‐19
title_fullStr Recurring nodular scleritis following inactivated vaccination for COVID‐19
title_full_unstemmed Recurring nodular scleritis following inactivated vaccination for COVID‐19
title_short Recurring nodular scleritis following inactivated vaccination for COVID‐19
title_sort recurring nodular scleritis following inactivated vaccination for covid‐19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264956/
https://www.ncbi.nlm.nih.gov/pubmed/37323271
http://dx.doi.org/10.1002/ccr3.7420
work_keys_str_mv AT peymanalireza recurringnodularscleritisfollowinginactivatedvaccinationforcovid19
AT pourazizimohsen recurringnodularscleritisfollowinginactivatedvaccinationforcovid19
AT dehghanishakiba recurringnodularscleritisfollowinginactivatedvaccinationforcovid19
AT ghorbanisarah recurringnodularscleritisfollowinginactivatedvaccinationforcovid19

Ejemplares similares